All lobbying filings

Miller Strategies, LLC

Miller Strategies, LLC filed a Q3 report for Amgen, Inc. on October 20, 2025, reporting $60,000 in lobbying income.

Lobbying for Amgen, Inc. · biopharmaceutical company

As filed: MILLER STRATEGIES, LLC for AMGEN, INC.

All filings by Miller Strategies, LLC · Everything Amgen, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

ASHLEY GUNN New on this filing

Previously held: Special Asst to the President, Senior Director, White House Office of Cabinet Affairs.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

Medicare/Medicaid

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Immigration

Issues related to visas

Bills named in this filing 1

H.R. 3517
Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.